. >> glaxo smith cline unveiling an expansion be plan today.could regulatory approval for up to 20 new treatments before the year 2020, the cao explains how reaching this goal would help the firm. >> that clearly is the fuel that can drive our pharma business and as we again, we saw in q3 as the different division are now moving to scale and the innovation starts to come through to the marketplace, we're getting optimistic about our ability to deliver earnings growth over the next five years. >> is an effort to rejuvenate its portfolio impacted by falling sales of key drugs. >> painkillers dispensed in the u.s. nearly quadrupled from 1999 to 2010, but americans report they still have the same amount of pain according to the centers for disease control and prevention. the c dp c also says that more than 20,000 people about 45 a day died last year from prescription pain killer overdoses. pretty grim statistics that make the alleged business practices of one publicly traded pharmaceutical company even more disturbing. we have more in the series "p